49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

33 trials found

diseases per page:

Showing 1 to 10 of 33 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-005028-11-NL (EUCTR)	23/09/2020	02/07/2020	A study of Baricitinib in patients with Lupus	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Bariciti ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1100	Phase 3	United States;Serbia;Philippines;Taiwan;Greece;Spain;Chile;Israel;Russian Federation;Colombia;Switze ...
2	EUCTR2017-005028-11-HR (EUCTR)	05/06/2020	23/11/2020	A study of Baricitinib in patients with Lupus	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Bariciti ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1100	Phase 3	United States;Serbia;Philippines;Taiwan;Greece;Spain;Chile;Israel;Russian Federation;Colombia;Switze ...
3	EUCTR2017-005028-11-GR (EUCTR)	20/05/2020	26/11/2019	A study of Baricitinib in patients with Lupus	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Bariciti ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1100	Phase 3	United States;Serbia;Philippines;Taiwan;Greece;Spain;Chile;Israel;Russian Federation;Colombia;Switze ...
4	EUCTR2017-005028-11-IT (EUCTR)	19/12/2019	22/01/2021	A study of Baricitinib in patients with Lupus	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Bariciti ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: [LY3009104] INN or Proposed INN: Baricitin ...	ELI LILLY & COMPANY, LILLY CORPORATE CENTER	NULL	Not Recruiting			Female: yes Male: yes	1100	Phase 3	Serbia;United States;Philippines;Taiwan;Greece;Spain;Ukraine;Chile;Russian Federation;Colombia;Switz ...
5	EUCTR2017-005028-11-GB (EUCTR)	24/10/2019	18/03/2019	A study of Baricitinib in patients with Lupus	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Bariciti ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1100	Phase 3	United States;Serbia;Philippines;Taiwan;Spain;Chile;Russian Federation;Colombia;Switzerland;Italy;In ...
6	EUCTR2017-005026-37-HR (EUCTR)	24/10/2019	20/01/2020	A study of Baricitinib in patients with Lupus	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinibin Patie ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	825	Phase 3	United States;Taiwan;Greece;Ukraine;Austria;Russian Federation;United Kingdom;Switzerland;Czech Repu ...
7	NCT03843125 (ClinicalTrials.gov)	September 9, 2019	14/2/2019	A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Bariciti ...	Systemic Lupus Erythematosus	Drug: Baricitinib	Eli Lilly and Company	Incyte Corporation	Terminated	18 Years	N/A	All	1156	Phase 3	United States;Argentina;Australia;Austria;Belgium;Brazil;Chile;China;Colombia;Croatia;Czechia;France ...
8	EUCTR2017-005026-37-NL (EUCTR)	06/08/2019	13/05/2019	A study of Baricitinib in patients with Lupus	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinibin Patie ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	825	Phase 3	United States;Czechia;Taiwan;Greece;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Switzer ...
9	EUCTR2017-005026-37-GR (EUCTR)	26/07/2019	03/05/2019	A study of Baricitinib in patients with Lupus	A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinibin Patie ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	825	Phase 3	United States;Taiwan;Greece;Ukraine;Austria;Israel;Russian Federation;United Kingdom;Switzerland;Cze ...
10	EUCTR2017-005028-11-RO (EUCTR)	22/07/2019	15/03/2022	A study of Baricitinib in patients with Lupus	A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Bariciti ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 21.1;Level: LLT;Classification code 10025139;Term ...	Trade Name: Olumiant Product Name: Baricitinib Product Code: LY3009104 INN or Proposed INN: Baricitinib ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1100	Phase 3	Serbia;United States;Philippines;Taiwan;Greece;Spain;Russian Federation;Chile;Colombia;Switzerland;I ...

First Previous1 2 3 4Next Last